Data sourced from Dakota Private Markets, the private fund performance platform powered by Dakota. Learn More | Request Access
EliseAI has closed a $350 million funding round at a $4 billion valuation, nearly doubling its worth from 13 months ago. The round was co-led by Andreessen Horowitz and Bessemer Venture Partners, with Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital also participating. The raise arrives as EliseAI surpassed $200 million in annual recurring revenue in June 2026, after doubling revenue year over year for five consecutive years.
The deal is not another AI infrastructure bet. It is a bet on vertical AI: industry-specific automation, embedded deep into the workflows of two sectors that together account for nearly 40% of U.S. household spending.
Why Investors Are Backing EliseAI
EliseAI was founded in 2017 by Minna Song and Tony Stoyanov, originally under the name MeetElise. Song spent time working inside a New York residential real estate firm specifically to understand, at ground level, how leasing operations actually ran. What she found was an industry drowning in repetitive, time-sensitive communications handled by understaffed teams. The company she built automates those communications end to end: leasing inquiries, tour scheduling, maintenance requests, renewal outreach, and resident communication across SMS, email, phone, and webchat.
The numbers reflect a product that has moved well beyond adoption. EliseAI's platform now powers roughly one in six U.S. apartments. More than 30 million Americans have interacted with its AI since launch. Roughly 70% of the 50 largest U.S. rental operators are customers. These are not pilot metrics. This is embedded infrastructure with compounding switching costs.
Healthcare, launched as a second vertical in 2023, applies the same automation engine to outpatient front-office work: patient intake, appointment scheduling, outbound calling, and billing tasks for specialty practices including women's health, dermatology, ophthalmology, and orthopedics. The two verticals share a common operational skeleton: both industries run on high volumes of repetitive, time-sensitive messages that consume staff capacity and degrade the experience for residents and patients alike.
At a $4 billion valuation on $200 million in ARR, investors are paying for a platform with demonstrated category leadership, not a product still searching for fit.
What the Capital Unlocks
EliseAI has signaled that the raise will fund three priorities: accelerating product development, expanding engineering and sales teams across North America, and establishing San Francisco as a second engineering hub alongside its New York headquarters. The company recently launched Apollo, its first fully agentic AI teammate, designed to work across tasks end to end while escalating binding or judgment-heavy decisions to human operators. That product direction points toward where the company is heading: from automating individual workflows to running entire operational layers autonomously.
The participation of Ontario Teachers' Pension Plan as a new investor carries its own signal. Institutional allocators of that scale and sophistication do not enter proptech or healthtech rounds passively. They enter when a platform has demonstrated the revenue quality, retention, and market position to justify a long-duration bet. Ontario Teachers' involvement gives EliseAI both capital and institutional validation in a category that has historically struggled to attract that kind of backer.
Dakota Private Markets tracks Net IRR, TVPI, DPI, and RVPI across 18,000+ named private funds, benchmarked against true vintage-year and strategy peers. Request access to see how the funds in this space have actually performed.
A Structural Shift in How AI Capital Is Deploying
The EliseAI round reflects a broader reordering underway in private AI investment. The first wave of this cycle went to foundation model developers and infrastructure: OpenAI, Anthropic, xAI. The second wave is now concentrating around vertical AI companies that have converted AI capabilities into durable enterprise revenue in specific industries.
That shift matters for private markets. Foundation model companies attract capital because they are building the infrastructure layer. Vertical AI companies attract capital because they are building the application layer with defensible distribution. EliseAI owns the workflow in multifamily housing and is replicating that position in healthcare. Both sectors have long sales cycles, high switching costs, and fragmented incumbent software that has been slow to adopt AI natively. That combination creates durable competitive moats for early category leaders.
The investor composition reinforces this reading. Andreessen Horowitz has led or co-led three consecutive EliseAI rounds. Bessemer Venture Partners has deep experience backing vertical SaaS companies that achieve category dominance before competition catches up. Neither firm commits at this scale to companies they view as cyclically exposed.
Execution Risk Remains
The multifamily housing market is sensitive to interest rate cycles, construction starts, and occupancy trends. A sustained softening in rental demand compresses the urgency operators feel around leasing automation. EliseAI's growth has so far outrun macro headwinds, but the healthcare expansion introduces a different set of risks: longer procurement cycles, compliance complexity, and integration requirements with electronic health record systems that can slow deployment significantly.
Competition is also intensifying. Property management software incumbents are adding AI to existing systems. AI-native competitors like Funnel Leasing and Colleen AI are competing on overlapping workflows. EliseAI's own research shows that 76% of multifamily operators currently use multiple AI vendors and more than a quarter are actively prioritizing consolidation. That dynamic could work in EliseAI's favor as the consolidation winner, or create pricing pressure if operators use multiple vendors to keep any single provider from gaining too much leverage.
At a $4 billion valuation and $200 million in ARR, the multiple is high enough that sustaining the revenue trajectory is not optional. The Apollo agentic product and the healthcare expansion both need to convert into meaningful ARR over the next 12 to 18 months to justify the current price.
A Defining Moment for Vertical AI
If the foundation model era asked whether AI could perform at scale, the vertical AI era asks whether AI can generate durable enterprise revenue at scale in specific industries. EliseAI's trajectory answers that question in two sectors simultaneously.
For the broader private markets, this round signals that the most defensible AI businesses may not be the ones building the most powerful models. They may be the ones that got into an industry early, embedded deeply enough to become operationally essential, and are now expanding the surface area of what they automate before competitors can replicate their distribution.
The next phase for EliseAI will be defined by how quickly Apollo scales, how effectively healthcare revenue matures alongside the core housing business, and whether the company can hold its category leadership position as the competitive environment consolidates. How that plays out will shape not just EliseAI's trajectory, but the template for vertical AI at scale across private markets.
Follow the deals, valuations, and strategic moves shaping private markets. Discover how Dakota Private Markets helps investment firms stay ahead.
.jpg)
